Replies to post #291 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

Celldex bellyflop has been discussed in the last two sessions. Check out:

1) Key Opinion Leader Meeting; and
http://lifesci.rampard.com/20160504/reg.jsp

2) Earnings q & a
http://seekingalpha.com/article/3974924-vascular-biogenics-vblt-ceo-dror-harats-q1-2016-results-earnings-call-transcript?part=single

It has to do with patient selection. Celldex selected patients to get favorable results in phase 2 and bombed in phase 3. VBLT phase 2 patient is the same as phase 3. No guarantee for success but higher chance at replicating success in phase 2.